Palisades Investment Partners’s Delcath Systems DCTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$128K Sell
13,763
-253,375
-95% -$2.45M 0.05% 51
2025
Q4
$2.7M Buy
267,138
+4,196
+2% +$41.7K 1.02% 34
2025
Q3
$2.83M Sell
262,942
-7,368
-3% -$82.3K 1.11% 34
2025
Q2
$3.68M Buy
270,310
+99,226
+58% +$1.38M 1.61% 23
2025
Q1
$2.18M Buy
171,084
+1,757
+1% +$24.9K 1.09% 33
2024
Q4
$2.04M Buy
169,327
+19,671
+13% +$208K 0.86% 35
2024
Q3
$1.35M Buy
+149,656
New +$1.3M 0.59% 37

Other funds holding DCTH

Palisades Investment Partners's DCTH Position: Q1 2026 in Review

Palisades Investment Partners reduced its Delcath Systems (DCTH) stake by 95% in Q1 2026, selling an estimated $2.45M and leaving 13,763 shares worth $128K. The position accounts for 0.05% of the portfolio, ranked #51.

Palisades Investment Partners first reported a position in DCTH in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.68M in Q2 2025. 121 funds tracked by Wall St. Rank hold DCTH as of Q1 2026.

  • Palisades Investment Partners held 13,763 shares of Delcath Systems worth $128K as of Q1 2026.
  • Palisades Investment Partners sold 253,375 Delcath Systems shares in Q1 2026, an estimated $2.45M.
  • Delcath Systems made up 0.05% of Palisades Investment Partners's portfolio in Q1 2026, its #51 holding.
  • Palisades Investment Partners first reported a position in Delcath Systems in Q3 2024 and has held it in 7 quarters since.
  • Palisades Investment Partners's Delcath Systems position peaked at $3.68M in Q2 2025.
  • 121 funds tracked by Wall St. Rank held Delcath Systems as of Q1 2026.

Based on Palisades Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.